pyrazinamide has been researched along with Bile Duct Cancer in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magoula, I | 1 |
| Tsapas, G | 1 |
| Kountouras, J | 1 |
| Kountouras, I | 1 |
| Paletas, K | 1 |
1 other study available for pyrazinamide and Bile Duct Cancer
| Article | Year |
|---|---|
Cholangiocarcinoma and severe renal hypouricemia: a study of the renal mechanisms.
Topics: Adenoma, Bile Duct; Bile Duct Neoplasms; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; P | 1991 |